You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Genotype 4

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CYP3A4*22 Trial (Palbociclib 125Mg Tab, Ribociclib 200Mg Oral Tablet, Abemaciclib 150 MG Oral Tablet)

Not yet recruiting
  • CYP3A4*22
  • Palbociclib 125Mg Tab
  • +2 more
  • (no location specified)
Jan 10, 2023

Plaquenil -Induced Retinal Toxicity, With Evaluation of ABCA4

Recruiting
  • Genotype
  • Retinal Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

    Completed
    Has Results
    • HCV
    • +2 more
    • (no location specified)
    Jul 28, 2021

    Hepatitis C Virus Trial (ABT-493/ABT-530)

    Completed
    Has Results
    • Hepatitis C Virus
    • (no location specified)
    Jul 9, 2021

    Hereditary Haemorrhagic Telangiectasia Trial in Bron, Clermont-Ferrand, Montpellier (Cord blood sampling, Cord sampling)

    Not yet recruiting
    • Hereditary Haemorrhagic Telangiectasia
    • Cord blood sampling
    • Cord sampling
    • Bron, France
    • +2 more
    Nov 21, 2022

    Asthma Trial in United States (Dupilumab, Placebo)

    Recruiting
    • Asthma
    • Boston, Massachusetts
    • +6 more
    Dec 5, 2022

    Exercise Training, Executive Function, Aging Trial in Taipei City, Taipei (Multi-Domain Exercise Program, Control Group)

    Recruiting
    • Exercise Training
    • +2 more
    • Multi-Domain Exercise Program
    • Control Group
    • Taipei City, Taiwan
    • +1 more
    Jul 21, 2022

    Total Genotype Score, Growth, Maturation and Loading Exposure as

    Completed
    • Fractures in Children
    • +5 more
    • Total Genotype Risk Score
    • London, New Malden, United Kingdom
    • +1 more
    Jan 21, 2022

    Zepatier in Patients With Substance Use

    Active, not recruiting
    • Hepatitis C
    • +3 more
    • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
    • Chicago, Illinois
      University of Illinois at Chicago
    Jun 28, 2022

    SLC26A4 in CI Patients With EVA

    Active, not recruiting
    • Sensorineural Hearing Loss
    • Enlarged Vestibular Aqueduct
    • Cochlear implantation
    • (no location specified)
    Jun 21, 2021

    Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

    Completed
    Has Results
    • Hepatitis C Virus Infection
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Alzheimer 2 Due to Apoe4 Isoform Trial in Taipei (LI-40, MI-30, HI-16)

    Completed
    • Alzheimer Disease 2 Due to Apoe4 Isoform
    • LI-40
    • +2 more
    • Taipei, Taiwan
      Department of Physical Education and Sport Sciences, National Ta
    Dec 6, 2022

    Genotype-Phenotype Correlations in Patients With Alport Syndrome

    Recruiting
    • Alport Syndrome
      • Shanghai, China
        China Xinhua Hospital, Shanghai Jiao Tong University School of M
      Jun 24, 2021

      Different Antiviral Regimens for Hepatitis C Virus Relapse

      Unknown status
      • Hepatitis C
      • +2 more
      • directly acting antivirals
      • Alexandria, Egypt
        Alexandria University.
      Dec 4, 2020

      HIV Trial in France (Analytical Treatment Interruption (ATI))

      Not yet recruiting
      • HIV Infections
      • Analytical Treatment Interruption (ATI)
      • Aix-en-Provence, France
      • +29 more
      Jul 28, 2022

      Hepatitis C, Chronic Trial in Riyadh (Elbasvir, Grazoprevir 50-100Mg Oral Tablet)

      Completed
      • Hepatitis C, Chronic
      • Elbasvir, Grazoprevir 50-100Mg Oral Tablet
      • Riyadh, Saudi Arabia
        King Fahad Medical City
      Nov 18, 2020

      Hepatitis C Virus Infection Trial (SOF/RBV/PegINFa-2)

      Completed
      • Hepatitis C Virus Infection
      • (no location specified)
      May 6, 2020

      Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

      Recruiting
      • Chronic Hepatitis C Infection
      • PR4 + LDV/SOF + ASV 4 wk
      • +7 more
      • Beijing, Beijing, China
      • +1 more
      Aug 27, 2021

      Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,

      Completed
      Has Results
      • Hepatitis C Virus Infection
      • +3 more
      • (no location specified)
      Jul 8, 2021

      Hepatitis C Trial (Grazoprevir, Elbasvir, Ribavirin)

      Completed
      Has Results
      • Hepatitis C
      • (no location specified)
      Jan 15, 2021

      Chronic Hepatitis C Virus Infection Trial in Beni-Suef (SOF plus (OBV/PTV/r) plus RBV)

      Completed
      • Chronic Hepatitis C Virus Infection
      • SOF plus (OBV/PTV/r) plus RBV
      • Beni-Suef, Egypt
        Beni-Suef University
      May 13, 2020

      Aspergillosis Invasive, Fungal Infection Trial in Toronto (Voriconazole genotype-specific dosing, Standard of Care)

      Completed
      • Aspergillosis Invasive
      • Fungal Infection
      • Voriconazole genotype-specific dosing
      • Standard of Care
      • Toronto, Ontario, Canada
      • +1 more
      Nov 2, 2020

      Chronic Hepatitis C Virus Infection Trial ((SOF and DCV), (SOF, DCV, and RBV))

      Completed
      • Chronic Hepatitis C Virus Infection
      • (SOF and DCV)
      • (SOF, DCV, and RBV)
      • (no location specified)
      May 13, 2020

      Hepatitis C Virus Infection, Response to Therapy of Trial in Cairo (Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER])

      Withdrawn
      • Hepatitis C Virus Infection, Response to Therapy of
      • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
      • Cairo, Almanial, Egypt
        Kasr Alainy Hospital
      Apr 16, 2020